Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.


Apps and Online Platforms for Patients with Heart Failure


Cardiac Failure Review 2020;6:e14.

Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond


Cardiac Failure Review 2020;6:e16.

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use


08 July 2020


Cardiac Failure Review 2020;6:e19.

Treating Mitral Regurgitation in the Wake of COAPT


14 July 2020


US Cardiology Review 2020;14:e06.